Data / Form D filings / NEUROPRO THERAPEUTICS, INC.
NEUROPRO THERAPEUTICS, INC.: Form D filings
NEUROPRO THERAPEUTICS, INC., a biotechnology company in Yachats, OR, filed 3 Form D notices with the SEC between 2016 and 2023. The latest, on April 13, 2023, reports $5.1 million sold of a $5.1 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 18 Basalt Loop, Yachats, OR, 97498
- Phone
- (919) 812-0485
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- North Carolina
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1681407
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 13, 2023 | New notice | $5,092,696 | $5,092,696 | 2 | Mar 31, 2023 | sec.gov | |
| Dec 13, 2016 | Amendment | $220,000 | $215,950 | $4,050 | 4 | Jul 28, 2016 | sec.gov |
| Aug 3, 2016 | New notice | $165,000 | $165,000 | 2 | Jul 28, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Daryl W. Hochman | Executive Officer, Director | |
| Louis W. Serafini | Director | |
| Luciano W. Cacioppo | Director |
Other biotechnology companies in Oregon that filed recently
- UBIVAC, INC. $80,000 · Aug 27, 2026
- Trace Biosciences Inc. $8.3 million · Aug 12, 2026
Every Form D from the week of Apr 10, 2023 · All recent filings in Oregon · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what NEUROPRO THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.